Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Not Confirmed
Not Confirmed
19-22 October, 2025
Not Confirmed
Not Confirmed
20-22 October, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Industry Trade Show
Not Confirmed
19-22 October, 2025
Industry Trade Show
Not Confirmed
20-22 October, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-are-building-capabilities-to-stay-ahead-of-the-curve-and-align-with-future-needs-of-global-healthcare
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-chemexpress-invest-in-adc-facilities-cohance-to-set-up-oligonucleotide-facility-in-india
14 Oct 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/brogidirsen-ns-089ncnp-02-3-5-year-clinical-trial-data-for-the-treatment-of-duchenne-muscular-dystrophy-presented-at-2025-world-muscle-society-congress-302580951.html
19 Sep 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/fda-grants-orphan-drug-designation-to-ns-051ncnp-04--for-the-treatment-of-duchenne-muscular-dystrophy-302560287.html
09 Sep 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/fda-grants-fast-track-designation-to-ns-229-for-the-treatment-of-eosinophilic-granulomatosis-with-polyangiitis-302550236.html
01 Jul 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/ns-pharma-announces-strategic-alliance-with-boston-childrens-hospital-to-develop-new-therapies-for-rare-diseases-302494701.html
14 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/fda-accepts-biologics-license-application-for-mucopolysaccharidosis-ii-treatment-302454515.html
21 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/fda-grants-orphan-drug-designation-to-ns-229-for-the-treatment-of-eosinophilic-granulomatosis-with-polyangiitis-302431734.html
ABOUT THIS PAGE
NS Pharma is a supplier offers 1 products (APIs, Excipients or Intermediates).
Find a price of Ilginatinib bulk offered by NS Pharma